Literature DB >> 6299273

Superoxide dismutase-inhibitible reduction of cytochrome c by the alloxan radical. Implications for alloxan cytotoxicity.

C C Winterbourn.   

Abstract

Cytochrome c was reduced when superoxide was generated from xanthine oxidase in the presence of alloxan, and by the reaction of alloxan and with reduced glutathione. In each case, most of the reduction was inhibited by superoxide dismutase, but considerably more enzyme was required than with superoxide alone. This indicates that the superoxide dismutase-inhibitible cytochrome c reduction was mainly due to a direct reaction with the alloxan radical, and implies that other reactions that are inhibited by superoxide dismutase could be due to either alloxan radicals or superoxide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299273      PMCID: PMC1153906          DOI: 10.1042/bj2070609

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Influence of trace metals on alloxan cytotoxicity in pancreatic islets.

Authors:  K Grankvist; S Marklund; I B Täljedal
Journal:  FEBS Lett       Date:  1979-09-01       Impact factor: 4.124

2.  Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate.

Authors:  R E Heikkila; B Winston; G Cohen
Journal:  Biochem Pharmacol       Date:  1976-05-01       Impact factor: 5.858

3.  The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents.

Authors:  G Cohen; R E Heikkila
Journal:  J Biol Chem       Date:  1974-04-25       Impact factor: 5.157

4.  Pulse radiolytic investigations of the redox system alloxan-dialuric acid: evidence for a radical intermediate.

Authors:  C Houée-Levin; M Gardès-Albert; C Ferradini; J Pucheault
Journal:  Biochem Biophys Res Commun       Date:  1979-12-14       Impact factor: 3.575

5.  Inhibitors of superoxide dismutases: a cautionary tale.

Authors:  H M Hassan; H Dougherty; I Fridovich
Journal:  Arch Biochem Biophys       Date:  1980-02       Impact factor: 4.013

6.  Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator.

Authors:  L J Fischer; S A Hamburger
Journal:  Diabetes       Date:  1980-03       Impact factor: 9.461

7.  Dimethylurea: a radical scavenger that protects isolated pancreatic islets from the effects of alloxan and dihydroxyfumarate exposure.

Authors:  L J Fischer; S A Hamburger
Journal:  Life Sci       Date:  1980-04-28       Impact factor: 5.037

8.  Superoxide dismutase as an inhibitor of reactions of semiquinone radicals.

Authors:  C C Winterbourn; J K French; R F Claridge
Journal:  FEBS Lett       Date:  1978-10-15       Impact factor: 4.124

9.  Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro.

Authors:  K Grankvist; S Marklund; J Sehlin; I B Täljedal
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

10.  Alloxan-induced luminol luminescence as a tool for investigating mechanisms of radical-mediated diabetogenicity.

Authors:  K Grankvist
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

View more
  3 in total

1.  Analysis of the bacterial response to Ru(CO)3Cl(Glycinate) (CORM-3) and the inactivated compound identifies the role played by the ruthenium compound and reveals sulfur-containing species as a major target of CORM-3 action.

Authors:  Samantha McLean; Ronald Begg; Helen E Jesse; Brian E Mann; Guido Sanguinetti; Robert K Poole
Journal:  Antioxid Redox Signal       Date:  2013-04-16       Impact factor: 8.401

2.  Alloxan cytotoxicity is highly potentiated by plasma membrane- and lysosomal-associated iron--a study on a model system of cultured J-774 cells.

Authors:  H Zhang; U T Brunk
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

3.  Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids.

Authors:  B C Hüsken; J de Jong; B Beekman; R C Onderwater; W J van der Vijgh; A Bast
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.